Visualization of yellow fever virus infection in mice using a bioluminescent reporter virus

References

• Monath TP. Treatment of yellow fever. Antiviral Res. 2008;78:116–124.
   PubMed Web of Science ®Google Scholar
• Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, federated states of Micronesia. N Engl J Med. 2009;360:2536–2543.
   PubMed Web of Science ®Google Scholar
• Paules C, Fauci A. Yellow fever - once again on the radar screen in the americas. N Engl J Med. 2017;376:1397–1399.
   Web of Science ®Google Scholar
• Otshudiema J, Ndakala N, Mawanda E, et al. Yellow fever outbreak - kongo Central province, Democratic Republic of the Congo, August 2016. MMWR Morb Mortal Wkly Rep. 2017;66:335–338.
   Web of Science ®Google Scholar
• Tomlinson W, Hodgson RS. Centennial year of yellow fever eradication in New orleans and the United States, 1905-2005. J La State Med Soc. 2005;157:216–217.
   Google Scholar
• Gaythorpe KA, Hamlet A, Jean K, et al. The global burden of yellow fever. Elife. 2021;10:e64670.
   Web of Science ®Google Scholar
• Organisation WH. (20 3 2018). WHO Report on global surveillance of epidemic-prone infectious diseases - Yellow fever [EB/OL]. http://wwwwhoint/csr/resources/publications/yellowfev/CSR_ISR_2000_1/en/.
   Google Scholar
• Poland JD, Calisher CH, Monath TP, et al. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ. 1981;59:895–900.
   PubMed Web of Science ®Google Scholar
• de Menezes Martins R, da Luz Fernandes Leal M, Homma A. Serious adverse events associated with yellow fever vaccine. Hum Vaccin Immunother. 2015;11:2183–2187.
   PubMed Web of Science ®Google Scholar
• Florczak-Wyspianska J, Nawotczynska E, Kozubski W. Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report. Neurol Neurochir Pol. 2017;51:101–105.
   Web of Science ®Google Scholar
• Lamson DM, Ramani R, Kleabonas M, et al. An unusual case of influenza-like illness after yellow fever vaccination. J Clin Virol. 2014;60:67–69.
   Web of Science ®Google Scholar
• Leung WS, Chan MC, Chik SH, et al. First case of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) in Hong Kong. J Travel Med. 2016;23:taw020.
   Web of Science ®Google Scholar
• Martins RDM, Pavao AL, de Oliveira PM, et al. Adverse events following yellow fever immunization: report and analysis of 67 neurological cases in Brazil. Vaccine. 2014;32:6676–6682.
   Web of Science ®Google Scholar
• van de Pol EM, Gisolf EH, Richter C. A case suspected for yellow fever vaccine-associated viscerotropic disease in the Netherlands. J Travel Med. 2014;21:421–424.
   Web of Science ®Google Scholar
• Puschnik AS, Marceau CD, Ooi YS, et al. A small-molecule oligosaccharyltransferase inhibitor with Pan-flaviviral activity. Cell Rep. 2017;21:3032–3039.
   PubMed Web of Science ®Google Scholar
• Yin Z, Chen YL, Schul W, et al. An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A. 2009;106:20435–20439.
   PubMed Web of Science ®Google Scholar
• Ferreira AC, Reis PA, de Freitas CS, et al. (2018). Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication. doi:https://doi.org/10.1128/aac.01389-18.
   Google Scholar
• Hall MP, Unch J, Binkowski BF, et al. Engineered luciferase reporter from a deep Sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol. 2012;7:1848–1857.
   PubMed Web of Science ®Google Scholar
• Caine EA, Osorio JE, Williams BRG. In vivo imaging with bioluminescent enterovirus 71 allows for real-time 438 Visualization of tissue tropism and viral spread. J Virol. 2017;91:e01759-16.
   Web of Science ®Google Scholar
• Tran V, Moser LA, Poole DS, et al. Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J Virol. 2013;87:13321–13329.
   PubMed Web of Science ®Google Scholar
• Anindita PD, Sasaki M, Nobori H, et al. Generation of recombinant rabies viruses encoding NanoLuc luciferase for antiviral activity assays. Virus Res. 2016;215:121–128.
   PubMed Web of Science ®Google Scholar
• Bredenbeek PJ, Kooi EA, Lindenbach B, et al. A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol. 2003;84:1261–1268.
   PubMed Web of Science ®Google Scholar
• Liu ZY, Qin CF. Structure and function of cis-acting RNA elements of flavivirus. Rev Med Virol. 2020;30:e2092.
   Web of Science ®Google Scholar
• Goo L, Dowd KA, Smith AR, et al. Zika virus Is Not uniquely stable at physiological temperatures compared to other flaviviruses. MBio. 2016;7:e01396-16.
   Web of Science ®Google Scholar
• Velandia-Romero ML, Acosta-Losada O, Castellanos JE. In vivo infection by a neuroinvasive neurovirulent dengue virus. J Neurovirol. 2012;18:374–387.
   PubMed Web of Science ®Google Scholar
• Blaney JE, Wirblich C, Papaneri AB, et al. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and ebola viruses. J Virol. 2011;85:10605–10616.
   PubMed Web of Science ®Google Scholar
• Guirakhoo F, Zhang Z, Myers G, et al. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys. J Virol. 2004;78:9998–10008.
   PubMed Web of Science ®Google Scholar
• Pripuzova NS, Tereshkina NV, Gmyl LV, et al. Safety evaluation of chimeric langat/dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis. J Med Virol. 2009;81:1777–1785.
   Web of Science ®Google Scholar
• Chan YF, AbuBakar S. Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection. Virol J. 2005;2:74.
   Web of Science ®Google Scholar
• Li XF, Li XD, Deng CL, et al. Visualization of a neurotropic flavivirus infection in mouse reveals unique viscerotropism controlled by host type I interferon signaling. Theranostics. 2017;7:912–925.
   PubMed Web of Science ®Google Scholar
• Schoggins JW, Dorner M, Feulner M, et al. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A. 2012;109:14610–14615.
   Web of Science ®Google Scholar
• Rocha RF, Del Sarto JL, Gomes GF, et al. Type I interferons are essential while type II interferon is dispensable for protection against St. louis encephalitis virus infection in the mouse brain. Virulence. 2021;12:244–259.
   PubMed Web of Science ®Google Scholar
• Meier KC, Gardner CL, Khoretonenko MV, et al. A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog. 2009;5:e1000614.
   PubMed Web of Science ®Google Scholar
• Erickson AK, Pfeiffer JK. Spectrum of disease outcomes in mice infected with YFV-17D. J Gen Virol. 2015;96:1328–1339.
   Web of Science ®Google Scholar
• Kum DB, Boudewijns R, Ma J, et al. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice. Emerg Microbes Infect. 2020;9:520–533.
   PubMed Web of Science ®Google Scholar
• Li Z, Brecher M, Deng YQ, et al. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res. 2017;27:1046–1064.
   PubMed Web of Science ®Google Scholar
• Deng YQ, Zhang NN, Li CF, et al. Adenosine analog NITD008 Is a potent inhibitor of Zika virus. Open Forum Infect Dis. 2016;3:ofw175.
   PubMed Web of Science ®Google Scholar
• Deng YQ, Dai JX, Ji GH, et al. A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS One. 2011;6:e16059.
   Web of Science ®Google Scholar
• Li C, Deng YQ, Wang S, et al. 25-Hydroxycholesterol protects Host against Zika virus infection and Its associated microcephaly in a mouse model. Immunity. 2017;46:446–456.
   PubMed Web of Science ®Google Scholar
• Czako R, Vogel L, Lamirande EW, et al. (2017). In vivo imaging of influenza virus infection in immunized mice. 8.
   Google Scholar
• Honda T, Gomi S, Yamane D, et al. (2021). Development and characterization of a highly sensitive nanoluciferase-based immunoprecipitation system for the detection of anti-influenza virus HA antibodies. mSphere 6.
   Google Scholar
• Corver J, Lenches E, Smith K, et al. Fine mapping of a cis-acting sequence element in yellow fever virus RNA that is required for RNA replication and cyclization. J Virol. 2003;77:2265–2270.
   PubMed Web of Science ®Google Scholar